SINGULUS TECHNOLOGIES-BR (SNG.DE) Stock Fundamental Analysis

FRA:SNG • DE000A1681X5

1.595 EUR
+0.04 (+2.57%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SNG. SNG was compared to 111 industry peers in the Machinery industry. SNG has a bad profitability rating. Also its financial health evaluation is rather negative. SNG has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year SNG has reported negative net income.
  • SNG had a positive operating cash flow in the past year.
  • SNG had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: SNG reported negative operating cash flow in multiple years.
SNG.DE Yearly Net Income VS EBIT VS OCF VS FCFSNG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

  • With a Return On Assets value of -9.33%, SNG is not doing good in the industry: 86.49% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -9.33%
ROE N/A
ROIC N/A
ROA(3y)-7.67%
ROA(5y)-20.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNG.DE Yearly ROA, ROE, ROICSNG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400

1.3 Margins

  • Looking at the Gross Margin, with a value of 33.64%, SNG is doing worse than 65.77% of the companies in the same industry.
  • SNG's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SNG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.49%
GM growth 5Y2.84%
SNG.DE Yearly Profit, Operating, Gross MarginsSNG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

3

2. Health

2.1 Basic Checks

  • SNG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SNG remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for SNG remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, SNG has an improved debt to assets ratio.
SNG.DE Yearly Shares OutstandingSNG.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SNG.DE Yearly Total Debt VS Total AssetsSNG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -1.41, we must say that SNG is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.41, SNG is doing worse than 80.18% of the companies in the same industry.
  • The Debt to FCF ratio of SNG is 2.03, which is a good value as it means it would take SNG, 2.03 years of fcf income to pay off all of its debts.
  • SNG has a better Debt to FCF ratio (2.03) than 80.18% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.03
Altman-Z -1.41
ROIC/WACCN/A
WACC4.59%
SNG.DE Yearly LT Debt VS Equity VS FCFSNG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

  • SNG has a Current Ratio of 0.49. This is a bad value and indicates that SNG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of SNG (0.49) is worse than 96.40% of its industry peers.
  • SNG has a Quick Ratio of 0.49. This is a bad value and indicates that SNG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SNG has a Quick ratio of 0.39. This is amonst the worse of the industry: SNG underperforms 92.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.39
SNG.DE Yearly Current Assets VS Current LiabilitesSNG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

  • SNG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.90%, which is quite impressive.
  • Looking at the last year, SNG shows a small growth in Revenue. The Revenue has grown by 4.55% in the last year.
  • SNG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.82% yearly.
EPS 1Y (TTM)44.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-799.11%
Revenue 1Y (TTM)4.55%
Revenue growth 3Y3.33%
Revenue growth 5Y-0.82%
Sales Q2Q%-25.87%

3.2 Future

  • Based on estimates for the next years, SNG will show a very strong growth in Earnings Per Share. The EPS will grow by 141.83% on average per year.
  • SNG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.90% yearly.
EPS Next Y-1385.71%
EPS Next 2Y213.96%
EPS Next 3Y141.83%
EPS Next 5YN/A
Revenue Next Year-17.41%
Revenue Next 2Y2.97%
Revenue Next 3Y6.56%
Revenue Next 5Y9.9%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SNG.DE Yearly Revenue VS EstimatesSNG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
SNG.DE Yearly EPS VS EstimatesSNG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -20 -40 -60

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SNG. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 5.74 indicates a rather cheap valuation of SNG.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SNG indicates a rather cheap valuation: SNG is cheaper than 96.40% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. SNG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 5.74
SNG.DE Price Earnings VS Forward Price EarningsSNG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • 77.48% of the companies in the same industry are cheaper than SNG, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SNG indicates a rather cheap valuation: SNG is cheaper than 99.10% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.84
EV/EBITDA 21.3
SNG.DE Per share dataSNG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SNG's earnings are expected to grow with 141.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y213.96%
EPS Next 3Y141.83%

0

5. Dividend

5.1 Amount

  • SNG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SINGULUS TECHNOLOGIES-BR

FRA:SNG (2/27/2026, 7:00:00 PM)

1.595

+0.04 (+2.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-12
Earnings (Next)03-27
Inst Owners8.75%
Inst Owner ChangeN/A
Ins Owners6.24%
Ins Owner ChangeN/A
Market Cap14.20M
Revenue(TTM)75.80M
Net Income(TTM)-5.40M
Analysts83.33
Price Target2.96 (85.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.45%
PT rev (3m)-20.91%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-5100%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-25.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.74
P/S 0.19
P/FCF 0.84
P/OCF 0.75
P/B N/A
P/tB N/A
EV/EBITDA 21.3
EPS(TTM)-0.61
EYN/A
EPS(NY)0.28
Fwd EY17.41%
FCF(TTM)1.9
FCFY119.05%
OCF(TTM)2.12
OCFY133.14%
SpS8.52
BVpS-5.81
TBVpS-7.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.33%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.64%
FCFM 22.3%
ROA(3y)-7.67%
ROA(5y)-20.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.49%
GM growth 5Y2.84%
F-Score5
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.03
Debt/EBITDA 6.1
Cap/Depr 83.33%
Cap/Sales 2.64%
Interest Coverage N/A
Cash Conversion 945%
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.39
Altman-Z -1.41
F-Score5
WACC4.59%
ROIC/WACCN/A
Cap/Depr(3y)74.38%
Cap/Depr(5y)54.87%
Cap/Sales(3y)2.78%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-799.11%
EPS Next Y-1385.71%
EPS Next 2Y213.96%
EPS Next 3Y141.83%
EPS Next 5YN/A
Revenue 1Y (TTM)4.55%
Revenue growth 3Y3.33%
Revenue growth 5Y-0.82%
Sales Q2Q%-25.87%
Revenue Next Year-17.41%
Revenue Next 2Y2.97%
Revenue Next 3Y6.56%
Revenue Next 5Y9.9%
EBIT growth 1Y95.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-148%
EBIT Next 3Y50.37%
EBIT Next 5Y28.34%
FCF growth 1Y158.89%
FCF growth 3Y-23.96%
FCF growth 5YN/A
OCF growth 1Y173.26%
OCF growth 3Y-19.23%
OCF growth 5YN/A

SINGULUS TECHNOLOGIES-BR / SNG.DE FAQ

What is the fundamental rating for SNG stock?

ChartMill assigns a fundamental rating of 2 / 10 to SNG.DE.


What is the valuation status for SNG stock?

ChartMill assigns a valuation rating of 5 / 10 to SINGULUS TECHNOLOGIES-BR (SNG.DE). This can be considered as Fairly Valued.


How profitable is SINGULUS TECHNOLOGIES-BR (SNG.DE) stock?

SINGULUS TECHNOLOGIES-BR (SNG.DE) has a profitability rating of 1 / 10.


How financially healthy is SINGULUS TECHNOLOGIES-BR?

The financial health rating of SINGULUS TECHNOLOGIES-BR (SNG.DE) is 2 / 10.